BIO CEO & Investor Conference

February 8-9, 2021・New York Marriott Marquis

Buzz of BIO Voting

Buzz of BIO Logo

Voting is now closed. The Buzz of BIO contest provides an excellent opportunity for companies looking to make the connections needed to take their product to the next phase. Qualifying biotechs were nominated in each of the three categories: Public Therapeutic Biotech, Private Therapeutic Biotech, Diagnostics and Beyond.  One winner in each category will be chosen to receive a free company presentation at the BIO CEO & Investor Conference. 

Please note that the contest is open to U.S. companies only. Read the official contest rules here

View the Nominees

The companies with the most number of votes in each category at the end of the voting period will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors.

PublicTherapeuticBiotech
  • Developing a therapeutic intended for FDA review that addresses human health 
  • Publicly traded
  • U.S. headquartered 
PrivateTherapeuticBiotech
  • Developing a therapeutic intended for FDA review that addresses human health 
  • > $25MM raised by Nov. 2019, but not yet publicly traded
  • U.S. headquartered
DiagnosticsandBeyond
  • Primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies
  • U.S. headquartered